How artificial intelligence is driving innovation in the pharmaceutical industry
Author(s) -
Jackie Hunter
Publication year - 2019
Publication title -
the biochemist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.126
H-Index - 7
eISSN - 1740-1194
pISSN - 0954-982X
DOI - 10.1042/bio04105006
Subject(s) - pharmaceutical industry , business , disease , engineering , risk analysis (engineering) , medicine , pharmacology , pathology
Although disease affects everyone, and trillions of pounds have been spent on research and development, there are still thousands of diseases without any treatment. There are over 300 million people suffering from rare diseases for which no medicine will be developed anytime soon, unless we dramatically disrupt the existing economic and development models.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom